SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 186 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $2,960,401 | -75.7% | 30,700 | -69.4% | 0.05% | -77.5% |
| Q3 2023 | $12,170,488 | +112.5% | 100,400 | +100.8% | 0.23% | +129.3% |
| Q2 2023 | $5,726,000 | -64.4% | 50,000 | -57.2% | 0.10% | -70.8% |
| Q1 2023 | $16,101,163 | +589.2% | 116,819 | +547.9% | 0.34% | +516.4% |
| Q4 2022 | $2,336,327 | -88.3% | 18,030 | -90.0% | 0.06% | -88.2% |
| Q3 2022 | $19,904,000 | +230.7% | 180,060 | +124.2% | 0.47% | +193.7% |
| Q2 2022 | $6,019,000 | +168.7% | 80,300 | +180.0% | 0.16% | +178.9% |
| Q1 2022 | $2,240,000 | +142.4% | 28,678 | +270.0% | 0.06% | +96.6% |
| Q1 2019 | $924,000 | -32.6% | 7,750 | -38.3% | 0.03% | -46.3% |
| Q4 2018 | $1,370,000 | +69.6% | 12,553 | +151.1% | 0.05% | +217.6% |
| Q3 2018 | $808,000 | -32.1% | 5,000 | -44.4% | 0.02% | -41.4% |
| Q2 2018 | $1,190,000 | -72.3% | 9,000 | -87.1% | 0.03% | -80.4% |
| Q3 2016 | $4,299,000 | – | 70,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
| Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
| HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
| Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
| Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
| Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
| EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
| Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |